NEW YORK, Dec. 2 (GenomeWeb News) - The University of Michigan Medical School has won a $5.9 million grant from the National Institute of Allergy and Infectious Diseases to apply its proteomics research to help develop a widely used anthrax vaccine, the school said today.
Michiganwas chosen as one of seven government-funded Biodefense Proteomics Research Centers. Philip Hanna is co-director of the center and assistant professor of microbiology and immunology at the university.